TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8690106

Group type: EXPERIMENTAL
Intervention: Goserelin acetate 3.6 mg once monthly plus 600 mg/d iron
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Goserelin acetate 3.6 mg once monthly plus placebo iron
Number of subjects: 0

Group type: COMPARATOR
Intervention: Iron alone (600 mg/d)
Number of subjects: 0
Study: 1906962

Group type: EXPERIMENTAL
Intervention: Staff Service
Number of subjects: 937

Group type: COMPARATOR
Intervention: Resident Service
Number of subjects: 937
Study: 6370482

Group type: EXPERIMENTAL
Intervention: 100 mg tablets
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 200 mg tablets
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 2% suspension
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: All formulations
Number of subjects: 10
Study: 30264179

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) applied to the quadriceps muscle (850 nm, 5 J per diode)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 14
Study: 27872974

Group type: EXPERIMENTAL
Intervention: Ropivacaine group (Rop group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study: 25575755

Group type: EXPERIMENTAL
Intervention: Mental rotation training (comparing pairs of 2D or 3D objects and rotation games)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Active control (performing parallel non-spatial activities)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Passive control
Number of subjects: 48
Study: 24124921

Group type: EXPERIMENTAL
Intervention: Intralesional verapamil (ILV) 10 mg weekly for 12 weeks
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Intralesional verapamil (ILV) 10 mg weekly for 12 weeks + oral antioxidants (one tablet once a day for 3 months)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group (ILV monotherapy)
Number of subjects: 105
Study: 23045865

Group type: EXPERIMENTAL
Intervention: Softened lighting and music
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard lighting and music (implied control)
Number of subjects: 0
Study: 20237064

Group type: EXPERIMENTAL
Intervention: 20 mg beta-carotene
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: 40 mg beta-carotene
Number of subjects: 7
Study: 17334775

Group type: COMPARATOR
Intervention: Placebo non-competitive (PNon)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 80 mg propranolol non-competitive (betaNon)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Placebo in simulated competition (PCom)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Propranolol in simulated competition (betaCom)
Number of subjects: 10
Study: 16365469

Group type: EXPERIMENTAL
Intervention: Moderate-intensity guideline implementation
Number of subjects: 3219

Group type: EXPERIMENTAL
Intervention: High-intensity guideline implementation
Number of subjects: 3219

Group type: COMPARATOR
Intervention: Low-intensity guideline implementation
Number of subjects: 3219
Study: 12409829

Group type: EXPERIMENTAL
Intervention: Bentiromide test
Number of subjects: 18
Study: 9475575

Group type: EXPERIMENTAL
Intervention: Phenylephrine infusion
Number of subjects: 18

Group type: COMPARATOR
Intervention: Baseline (no phenylephrine)
Number of subjects: 18
Study: 7624490

Group type: EXPERIMENTAL
Intervention: Butocamide hydrogen succinate (BAHS) 600 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nitrazepam 5 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: BAHS 600 mg + Nitrazepam 5 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Inert placebo
Number of subjects: 12
Study: 2196359

Group type: EXPERIMENTAL
Intervention: Captopril (0.9 mg/kg/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 359752

Group type: EXPERIMENTAL
Intervention: Intramuscular benzathine penicillin G alone
Number of subjects: 127

Group type: COMPARATOR
Intervention: Intramuscular benzathine penicillin G combined with hexachlorophene scrubbing
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Children whose skin cultures grew Group A beta hemolytic streptococci
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Children with staphylococcus aureus as the only pathogen isolated
Number of subjects: 127

Group type: COMPARATOR
Intervention: Hexachlorophene scrubbing (regardless of pathogens isolated)
Number of subjects: 127
Study: 30669618

Group type: EXPERIMENTAL
Intervention: 40 μM Epigallocatechin-3-gallate (EGCG)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 100 μM Epigallocatechin-3-gallate (EGCG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated control
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: EGCG treatment
Number of subjects: 0
Study: 29129251

Group type: EXPERIMENTAL
Intervention: Edoxaban 60 mg (or 30 mg for specific conditions)
Number of subjects: 2199

Group type: COMPARATOR
Intervention: Enoxaparin-warfarin
Number of subjects: 2199

Group type: EXPERIMENTAL
Intervention: Edoxaban
Number of subjects: 2199

Group type: EXPERIMENTAL
Intervention: Edoxaban and Enoxaparin-warfarin
Number of subjects: 2199
Study: 25280445

Group type: EXPERIMENTAL
Intervention: Flow diversion with Pipeline™ Embolization Device
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional endovascular strategy
Number of subjects: 0
Study: 23033246

Group type: EXPERIMENTAL
Intervention: Simvastatin plus fenofibrate (FENO‐S)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Simvastatin plus placebo (PL‐S)
Number of subjects: 139
Study: 22470031

Group type: EXPERIMENTAL
Intervention: Inulin, FOS and ALA enriched cookie
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control cookie
Number of subjects: 36
Study: 19181980

Group type: EXPERIMENTAL
Intervention: Hinged ankle-foot orthoses
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Dynamic ankle-foot orthoses
Number of subjects: 15

Group type: COMPARATOR
Intervention: Barefoot condition
Number of subjects: 15
Study: 17144178

Group type: EXPERIMENTAL
Intervention: BiDil
Number of subjects: 0
Study: 15000354

Group type: EXPERIMENTAL
Intervention: Chronic WAD subjects
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 10991842

Group type: EXPERIMENTAL
Intervention: saquinavir-SGC (1,200 to 1,800 mg) plus ritonavir (100 to 200 mg)
Number of subjects: 44

Group type: COMPARATOR
Intervention: saquinavir-SGC (1,200 mg) three times daily
Number of subjects: 44
Study: 8969617

Group type: EXPERIMENTAL
Intervention: Calcium supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin D treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exercise interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy and bisphosphonates
Number of subjects: 0
Study: 1311663

Group type: EXPERIMENTAL
Intervention: 111In‐labelled granulocytes
Number of subjects: 8
Study: 3993612

Group type: EXPERIMENTAL
Intervention: Nutrient-rich dietary supplement (group A)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Placebo (group B)
Number of subjects: 225
Study: 31575824

Group type: EXPERIMENTAL
Intervention: Foot-toe orthosis and laboratory-issued shoe group
Number of subjects: 64

Group type: COMPARATOR
Intervention: Laboratory-issued shoe only (SO) group
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 64
Study: 28771018

Group type: EXPERIMENTAL
Intervention: Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 46
Study: 27973414

Group type: EXPERIMENTAL
Intervention: Height-adjustable desks with pedagogical strategies to reduce/break-up sitting
Number of subjects: 48

Group type: COMPARATOR
Intervention: Traditional furniture (control)
Number of subjects: 48
Study: 23908187

Group type: EXPERIMENTAL
Intervention: FIN-RACo+INFL (infliximab 3 mg/kg)
Number of subjects: 99

Group type: COMPARATOR
Intervention: FIN-RACo+PLA (placebo)
Number of subjects: 99
Study: 22749176

Group type: EXPERIMENTAL
Intervention: Cinnamon extract (low-dose at 120 mg/d)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Cinnamon extract (high-dose at 360 mg/d)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 20414661

Group type: EXPERIMENTAL
Intervention: Disimpaction for the first week and daily laxative (Group A1)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Only daily laxative (Group A2)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Disimpaction for the first week and daily laxative (Group B1)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Only daily laxative (Group B2)
Number of subjects: 270
Study: 18689552

Group type: EXPERIMENTAL
Intervention: Flaxseed oil (6 g of ALA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Milled flaxseed (30 g)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Whole flaxseed (30 g)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no specific control group mentioned)
Number of subjects: 0
Study: 16422825

Group type: EXPERIMENTAL
Intervention: Tadalafil 20 mg on-demand treatment
Number of subjects: 4262

Group type: EXPERIMENTAL
Intervention: Tadalafil 3 times/week treatment
Number of subjects: 4262

Group type: COMPARATOR
Intervention: Both regimens
Number of subjects: 4262
Study: 15540759

Group type: EXPERIMENTAL
Intervention: Doxazosin 8 mg with Tadalafil 20 mg
Number of subjects: 36

Group type: COMPARATOR
Intervention: Tamsulosin 0.4 mg with Tadalafil 10 mg
Number of subjects: 36

Group type: COMPARATOR
Intervention: Tamsulosin 0.4 mg with Tadalafil 20 mg
Number of subjects: 36
Study: 11375359

Group type: EXPERIMENTAL
Intervention: Group consultations every 3 months
Number of subjects: 112

Group type: COMPARATOR
Intervention: Individual visits plus support education every 3 months
Number of subjects: 112
Study: 9245040

Group type: EXPERIMENTAL
Intervention: Deflazacort
Number of subjects: 30

Group type: COMPARATOR
Intervention: Prednisolone
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 30
Study: 8488476

Group type: EXPERIMENTAL
Intervention: Sodium valproate
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 3553274

Group type: EXPERIMENTAL
Intervention: Essential fatty acid (EFA) supplementation (evening primrose oil; Efamol)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 30426183

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: EEG spectra
Number of subjects: 0
Study: 26859644

Group type: EXPERIMENTAL
Intervention: Compression stockings (24 or 30 mmHg ankle pressure)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Regular stockings (no compression)
Number of subjects: 9
Study: 24935082

Group type: EXPERIMENTAL
Intervention: Medication management plus CBT
Number of subjects: 144

Group type: COMPARATOR
Intervention: Medication management only
Number of subjects: 144
Study: 22874692

Group type: EXPERIMENTAL
Intervention: Intramuscular diclofenac 75 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Transdermal diclofenac
Number of subjects: 60
Study: 21029642

Group type: EXPERIMENTAL
Intervention: Supreme LMA (S)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Endotracheal tube (T)
Number of subjects: 125
Study: 19128643

Group type: EXPERIMENTAL
Intervention: DizzyFix device
Number of subjects: 50

Group type: COMPARATOR
Intervention: Non-device users (control)
Number of subjects: 50
Study: 16400464

Group type: EXPERIMENTAL
Intervention: Diet (D)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Diet plus exercise training (D + ET)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Nonadherent (NA)
Number of subjects: 53
Study: 15643758

Group type: EXPERIMENTAL
Intervention: Chewing stick (miswak)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Toothbrushing
Number of subjects: 15
Study: 11341172

Group type: EXPERIMENTAL
Intervention: High levels of anti-insulin antibodies (AB1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Elevated levels of antiidiotypic antibodies (AIAb2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High levels of anti-insulin/NGF Ab1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Children with elevated levels of Ab1 at age 1-3 years
Number of subjects: 0
Study: 8780345

Group type: EXPERIMENTAL
Intervention: Lean mass
Number of subjects: 1600

Group type: EXPERIMENTAL
Intervention: Fat mass
Number of subjects: 1600

Group type: EXPERIMENTAL
Intervention: Body weight
Number of subjects: 1600
Study: 1384299

Group type: EXPERIMENTAL
Intervention: cetirizine 10 mg
Number of subjects: 6

Group type: COMPARATOR
Intervention: terfenadine 60 mg
Number of subjects: 6
Study: 2999514

Group type: EXPERIMENTAL
Intervention: Telephone aftercare contacts every 2 weeks for 1 year
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual treatment (control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Telephone aftercare contacts
Number of subjects: 0
Study: 30440913

Group type: EXPERIMENTAL
Intervention: 1Hz rTMS treatment 4 days/week for 3 weeks followed by 30min occupational therapy (OT)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Sham rTMS for 3 weeks followed by sham rTMS combined with OT for 3 weeks
Number of subjects: 4
Study: 26784537

Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy (CBT) for aggression, 12 sessions
Number of subjects: 80

Group type: COMPARATOR
Intervention: Supportive psychotherapy, 12 sessions
Number of subjects: 80
Study: 25180279

Group type: EXPERIMENTAL
Intervention: Hydroxyurea
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22494016

Group type: EXPERIMENTAL
Intervention: Biventricular (BIV) pacing
Number of subjects: 11

Group type: COMPARATOR
Intervention: Right ventricular (RV) pacing
Number of subjects: 11
Study: 19900348

Group type: EXPERIMENTAL
Intervention: Multifaceted strategy training for executive dysfunction
Number of subjects: 75

Group type: COMPARATOR
Intervention: Computerized cognitive function training
Number of subjects: 75
Study: 19093057

Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Metronidazole plus amoxicillin
Number of subjects: 31
Study: 16280177

Group type: EXPERIMENTAL
Intervention: Foscarnet (1 g/day for 4 weeks)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Foscarnet (in vitro and in vivo)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Foscarnet (in vivo)
Number of subjects: 65
Study: 12438980

Group type: EXPERIMENTAL
Intervention: Patients with flatback deformity
Number of subjects: 21

Group type: COMPARATOR
Intervention: Normal healthy individuals
Number of subjects: 21
Study: 10048641

Group type: EXPERIMENTAL
Intervention: Philips HP 735 powered toothbrush
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Braun/Oral B D7 powered toothbrush
Number of subjects: 75

Group type: COMPARATOR
Intervention: Oral B Advantage B35 manual toothbrush
Number of subjects: 75
Study: 7560663

Group type: EXPERIMENTAL
Intervention: Cromolyn sodium (10 mg)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (4 mg)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 2134003

Group type: EXPERIMENTAL
Intervention: Beveled preparations
Number of subjects: 43

Group type: COMPARATOR
Intervention: Non-beveled preparations
Number of subjects: 43
Study: 7002477

Group type: EXPERIMENTAL
Intervention: Cyclopenthiazide and oxprenolol
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cyclopenthiazide alone
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 30557080

Group type: EXPERIMENTAL
Intervention: Simultaneous steroid injection after percutaneous A1 pulley release
Number of subjects: 112

Group type: COMPARATOR
Intervention: Percutaneous A1 pulley release alone
Number of subjects: 112
Study: 28495619

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin DPI 32.5mg twice daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26368396

Group type: EXPERIMENTAL
Intervention: Oxytocin (OT)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Control (placebo or no treatment)
Number of subjects: 156
Study: 23373793

Group type: EXPERIMENTAL
Intervention: SRP + aPDT
Number of subjects: 15

Group type: COMPARATOR
Intervention: SRP
Number of subjects: 15
Study: 21311753

Group type: EXPERIMENTAL
Intervention: Working memory content with categorical similarity (digits)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Working memory content
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition (colors and digits)
Number of subjects: 0
Study: 19586135

Group type: COMPARATOR
Intervention: Standard care plus assessment (SC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standard care plus brief motivational intervention (BI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BI plus a booster session (BIB)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BI and BIB
Number of subjects: 0

Group type: COMPARATOR
Intervention: SC
Number of subjects: 0
Study: 17762374

Group type: COMPARATOR
Intervention: EHIGH
Number of subjects: 62

Group type: COMPARATOR
Intervention: EMODERATE
Number of subjects: 62
Study: 15126813

Group type: EXPERIMENTAL
Intervention: Clinical diagnostic algorithm for stress urinary incontinence (SUI) based on symptoms and signs
Number of subjects: 1455
Study: 11403530

Group type: EXPERIMENTAL
Intervention: Modafinil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amphetamine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methamphetamine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Selegiline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pemoline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tricyclic antidepressants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Scheduled naps
Number of subjects: 0
Study: 10894290

Group type: EXPERIMENTAL
Intervention: Single Method (SM) counseling (male or female condoms only)
Number of subjects: 1591

Group type: EXPERIMENTAL
Intervention: Hierarchical Message (HP) counseling (male condoms, female condoms, diaphragms, cervical caps, and spermicides)
Number of subjects: 1591
Study: 8895711

Group type: EXPERIMENTAL
Intervention: Meperidine 100 mg IM intraoperative preprocedure
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Meperidine 100 mg IM intraoperative postprocedure
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Ketorolac tromethamine 60 mg IM intraoperative preprocedure
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Ketorolac tromethamine 60 mg IM postprocedure
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control placebo
Number of subjects: 125
Study: 1364801

Group type: EXPERIMENTAL
Intervention: Combined roentgenoradionuclide investigation of the lungs
Number of subjects: 45
Study: 6343155

Group type: EXPERIMENTAL
Intervention: Flurbiprofen 300 mg/day
Number of subjects: 118

Group type: COMPARATOR
Intervention: Naproxen 750 mg/day
Number of subjects: 118
Study: 30611135

Group type: EXPERIMENTAL
Intervention: Strokectomy after decompressive craniectomy
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Strokectomy in patients with infarctions in more than one vascular territory
Number of subjects: 198

Group type: COMPARATOR
Intervention: Strokectomy group vs. matched control group
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Strokectomy group
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Münster Stroke Score ≥ 3
Number of subjects: 198
Study: 29394211

Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS)
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: Other Nerve Stimulation Therapies (NSTs)
Number of subjects: 700

Group type: COMPARATOR
Intervention: Control treatment (sham, placebo, or medication only)
Number of subjects: 700
Study: 27129840

Group type: EXPERIMENTAL
Intervention: Home-based yoga
Number of subjects: 34

Group type: COMPARATOR
Intervention: Strengthening exercises
Number of subjects: 34
Study: 25345982

Group type: EXPERIMENTAL
Intervention: RIF‐MMX (2×200 mg twice daily for 3 days)
Number of subjects: 264

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: RIF‐MMX
Number of subjects: 264
Study: 22772089

Group type: EXPERIMENTAL
Intervention: Interprofessional communication intervention involving a trained communication facilitator (nurse or social worker)
Number of subjects: 0
Study: 20397782

Group type: EXPERIMENTAL
Intervention: Hazard perception training package
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control intervention video
Number of subjects: 20
Study: 18628111

Group type: EXPERIMENTAL
Intervention: Hitting a ball dropped from a ramp from 5 heights (1.5, 2.0, 2.5, 3.0, and 3.5 m)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Hitting a moving ball while stepping
Number of subjects: 9
Study: 15901742

Group type: EXPERIMENTAL
Intervention: Progesterone cream 40 mg twice daily for 12 days
Number of subjects: 12

Group type: COMPARATOR
Intervention: Oral progesterone capsules 200 mg once daily for 12 days
Number of subjects: 12
Study: 12556074

Group type: EXPERIMENTAL
Intervention: Low calcium dialysate (1.25 mmol/L calcium)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Standard dialysate (1.75 mmol/L calcium)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 28
Study: 10047632

Group type: EXPERIMENTAL
Intervention: Atrial fibrillation (AF)
Number of subjects: 3465

Group type: COMPARATOR
Intervention: Sinus rhythm
Number of subjects: 3465

Group type: EXPERIMENTAL
Intervention: Age and body weight
Number of subjects: 3465

Group type: EXPERIMENTAL
Intervention: Prolonged duration of AF, left ventricular dilatation, increased muscle mass, mitral regurgitation, annular calcification, and hypertension
Number of subjects: 3465
Study: 7726669

Group type: EXPERIMENTAL
Intervention: Supplemental enteral feeding (arginine + omega-3 fatty acids)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard enteral feeding
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Tube feeding
Number of subjects: 60

Group type: COMPARATOR
Intervention: No tube feeding
Number of subjects: 60
Study: 2291881

Group type: EXPERIMENTAL
Intervention: 10 ml of 0.25% bupivacaine plain
Number of subjects: 55

Group type: COMPARATOR
Intervention: 10 ml of 0.25% bupivacaine with epinephrine 1:200,000
Number of subjects: 55